CCM Biosciences has developed groundbreaking compounds that activate the enzyme SIRT3, potentially reversing age-related cellular decline. These first-in-class drugs outperform existing treatments...
BEIJING — A growing number of countries are confronting the dual challenges of population decline and aging, as younger generations opt to...